HomeSTX • LON
add
Shield Therapeutics PLC
Previous close
GBX 1.55
Day range
GBX 1.50 - GBX 1.62
Year range
GBX 1.06 - GBX 12.85
Market cap
12.21M GBP
Avg Volume
5.01M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 2.17M | 65.80% |
Operating expense | 6.90M | -16.52% |
Net income | -6.30M | 16.62% |
Net profit margin | -290.84 | 49.71% |
Earnings per share | — | — |
EBITDA | -5.70M | 16.90% |
Effective tax rate | -6.89% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 13.59M | 365.36% |
Total assets | 41.67M | -4.28% |
Total liabilities | 14.56M | 268.58% |
Total equity | 27.10M | — |
Shares outstanding | 713.04M | — |
Price to book | 0.39 | — |
Return on assets | -34.62% | — |
Return on capital | -43.88% | — |
Cash Flow
Net change in cash
(USD) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -6.30M | 16.62% |
Cash from operations | -9.95M | -38.81% |
Cash from investing | -659.00K | -4.19% |
Cash from financing | 15.06M | 25,000.83% |
Net change in cash | 5.10M | 175.68% |
Free cash flow | -4.26M | -4.56% |
About
CEO
Founded
2008
Website
Employees
27